: While adjusted EBITDA reached $18.5 million , Aurora still reported a net loss of $51.6 million in Q3 2026, driven by costs rather than top-line movement alone.
: Global medical cannabis now accounts for 81% of total revenue and 95% of adjusted gross profit , with medical margins holding steady at 69% . Market Sentiment & Ratings buy acb stock
: The company maintains a "cannabis debt-free" balance sheet with $154.4 million in cash as of December 31, 2025. : While adjusted EBITDA reached $18
Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks. buy acb stock